Breaking News – FSD Pharma Announces Decision to Surrender Health Canada Licenses – Selling Cobourg Plant

In Local

FV Pharma to shut down operations within 30 days –

FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced that it has notified Health Canada of the Company’s decision to forfeit the licenses of its wholly-owned subsidiary, FV Pharma, Inc. (“FV Pharma”) and suspend all activities by FV Pharma within 30 days of the notification date. FSD Pharma has begun the process of liquidating all FV Pharma assets, including the sale of the Company’s cannabis production facility in Cobourg, Ontario.

“It is now clear to us that our shareholder value is best served in closing down our medicinal grade cannabis operation in Cobourg, Ontario and reinforcing steps to advance pharmaceutical R&D efforts on our lead compound FSD201 (ultra-micronized PEA) and continuing to explore the acquisition of other compelling compounds to expand our drug development pipeline,” said Raza Bokhari, MD, Executive Co-Chairman & CEO.

“Our pharmaceutical R&D team led by Dr. Edward Brennan is actively working to submit an Investigational New Drug Application (IND) to the FDA for the use of FSD201 (ultra-micronized PEA) to treat hospitalized COVID-19 patients by down-regulating the over-expressed pro-inflammatory cytokine immune response to SARS-CoV-2 virus infection. We are hopeful to initiate the phase 2 clinical trial before the end of this year and remain cautiously optimistic that our study may improve treatment outcome for COVID-19 patients.”

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.

About FSD Pharma

FSD Pharma Inc. is a publicly-traded holding company, since May 2018.

FSD Pharma BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound FSD201, by down-regulating the cytokines to effectuate an anti-inflammatory response.

Pete Fisher
Author: Pete Fisher

Has been a photojournalist for over 30-years and have been honoured to win numerous awards for photography and writing over the years. Best selling author for the book Highway of Heroes - True Patriot Love

Join Our Newsletter!

Want to keep up to date on news and events in Northumberland? Subscribe to newsletter!

You may also read!

Ontario Expanding Eligibility for Tariff Support Programs

In response to the United States government’s latest actions targeting Ontario workers and businesses, the Ontario government is expanding eligibility under

Read More...

Premier Ford Unveils Changes to Cabinet to Put Ontario on Long-Term Footing to Fight President Trump’s Tariffs

Changes will support government’s plan to protect workers and businesses by building the most competitive, resilient and self-reliant economy

Read More...

Video – Durham Region Police – Suspects Arrested Following Project Magenta Investigation into Organized Property Crime (Names Released)

Project Magenta | Videos & Movies on Vimeo Two adult males and two male youth are facing more than 200

Read More...

Mobile Sliding Menu